|
1
|
Strauss LG and Conti PS: The applications
of PET in clinical oncology. J Nucl Med. 32:623–650.
1991.PubMed/NCBI
|
|
2
|
Halter G, Buck AK, Schirrmeister H, et al:
[18F] 3-deoxy-3′-fluorothymidine positron emission
tomography: alternative or diagnostic adjunct to
2-[18F]-fluoro-2-deoxy-D-glucose positron emission
tomography in the workup of suspicious central focal lesions? J
Thorac Cardiovasc Surg. 127:1093–1099. 2004.
|
|
3
|
Haberkorn U, Bellemann ME, Brix G, et al:
Apoptosis and changes in glucose transport early after treatment of
Morris hepatoma with gemcitabine. Eur J Nucl Med. 28:418–425. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Burgman P, Odonoghue JA, Humm JL and Ling
CC: Hypoxia induced increase in FDG uptake in MCF7 cells. J Nucl
Med. 42:170–175. 2001.PubMed/NCBI
|
|
5
|
Bakheet SM, Saleem M, Powe J, Al-Amro A,
Larsson SG and Mahassin Z: F-18 fluorodeoxyglucose chest uptake in
lung inflammation and infection. Clin Nucl Med. 25:273–278. 2000.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Bakheet SM and Powe J: Benign causes of
18-FDG uptake on whole body imaging. Semin Nucl Med. 28:352–358.
1998. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Minn H, Clavo AC, Grénman R and Wahl RL:
In vitro comparison of cell proliferation kinetics and uptake of
tritiated fluorodeoxyglucose and L-methionine in squamous-cell
carcinoma of the head and neck. J Nucl Med. 36:252–258.
1995.PubMed/NCBI
|
|
8
|
Eriksson S, Munch-Petersen B, Johansson K
and Eklund H: Structure and function of cellular
deoxyribonucleoside kinases. Cell Mol Life Sci. 59:1327–1346. 2002.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Rasey JS, Grierson JR, Wiens LW, Kolb PD
and Schwartz JL: Validation of FLT uptake as a measure of thymidine
kinase-1 activity in A549 carcinoma cells. J Nucl Med.
43:1210–1217. 2002.PubMed/NCBI
|
|
10
|
Carter EA, McCusker C, Syed S, Tompkins RG
and Fischman AJ: Comparison of 18FLT with
18FDG for differentiation between tumor and focal sites
of infection in rats. J Nucl Med. 43:2662002.
|
|
11
|
van Waarde A, Cobben DCP, Suurmeijer AJH,
et al: Selectivity of 18F-FLT and 18F-FDG for
differentiating tumor from inflammation in a rodent model. J Nucl
Med. 45:695–700. 2004.
|
|
12
|
Boerman OC, Storm G, Oyen WJ, et al:
Sterically stabilized liposomes labeled with indium-111 to image
focal infection. J Nucl Med. 36:1639–1644. 1995.PubMed/NCBI
|
|
13
|
Francis DL, Visvikis D, Costa DC, et al:
Potential impact of [18F]3′-deoxy-3′-fluorothymidine
versus [18F]fluoro-2-deoxy-D-glucose in positron
emission tomography for colorectal cancer. Eur J Nucl Med Mol
Imaging. 30:988–994. 2003.
|
|
14
|
Munch-Petersen B, Cloos L, Jensen HK and
Tyrsted G: Human thymidine kinase 1. Regulation in normal and
malignant cells. Adv Enzyme Regul. 35:69–89. 1995. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Been LB, Suurmeijer AJ, Cobben DC, Jager
PL, Hoekstra HJ and Elsinga PH: [18F]FLT-PET in
oncology: current status and opportunities. Eur J Nucl Med Mol
Imaging. 31:1659–1672. 2004.
|
|
16
|
Shields AF: PET imaging with
18F-FLT and thymidine analogs: promise and pitfalls. J
Nucl Med. 44:1432–1434. 2003.PubMed/NCBI
|
|
17
|
Wagner M, Seitz U, Buck A, et al:
3′-[18F]fluoro-3′-deoxythymidine ([18F]-FLT)
as positron emission tomography tracer for imaging proliferation in
a murine B-cell lymphoma model and in the human disease. Cancer
Res. 63:2681–2687. 2003.
|
|
18
|
Dittmann H, Dohmen BM, Kehlbach R, et al:
Early changes in [18F]FLT uptake after chemotherapy: an
experimental study. Eur J Nucl Med Mol Imaging. 29:1462–1469.
2002.
|
|
19
|
Chen W, Cloughesy T, Kamdar N, et al:
Imaging proliferation in brain tumors with 18F-FLT PET:
comparison with 18F-FDG. J Nucl Med. 46:945–952.
2005.PubMed/NCBI
|
|
20
|
Sugawara Y, Gutowski TD, Fisher SJ, Brown
RS and Wahl RL: Uptake of positron emission tomography tracers in
experimental bacterial infections: a comparative biodistribution
study of radiolabeled FDG, thymidine, L-methionine,
67Ga-citrate, and 125I-HSA. Eur J Nucl Med.
26:333–341. 1999. View Article : Google Scholar
|
|
21
|
Vesselle H, Grierson J, Muzi M, et al: In
vivo validation of 3′deoxy-3′-[(18)F]fluorothymidine ([(18)F]FLT)
as a proliferation imaging tracer in humans: correlation of
[(18)F]FLT uptake by positron emission tomography with Ki-67
immunohistochemistry and flow cytometry in human lung tumors. Clin
Cancer Res. 8:3315–3323. 2002.
|
